Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: From the liver to the kidney

Dig Liver Dis. 2014 Nov;46(11):1001-7. doi: 10.1016/j.dld.2014.06.013. Epub 2014 Aug 2.

Abstract

Background: The aim of this retrospective study was to evaluate the prognostic value of different scores (including Child-Pugh and Model for End Stage Liver Diseases) in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt for refractory ascites.

Methods: Overall, 111 patients with transjugular intrahepatic porto-systemic shunt insertion between January 1998 and July 2012 were included.

Results: Survival rates (without transplantation) were 82.0% at 3 months, and 59.4% at 1 year. In addition to standard parameters, a new simple classification based on platelet count and glomerular filtration rate showed strong prognostic ability and could distinguish 3 groups of patients (Log-rank test, p<0.001): a "good-prognosis" group with platelet counts above 125×10(9)L(-1) and a glomerular filtration rate above 90 mL/min (1-year survival rate 92%), a "poor-prognosis" group with platelet counts below 125×10(9)L(-1) and a glomerular filtration rate below 90 mL/min (1-year survival rate 34.8%), and an "intermediate-prognosis" group (1-year survival rate 58.2%). Multivariate analysis showed a hazard ratio of 6.34 for the intermediate class and of 12.623 for the high class.

Conclusions: A new and simple classification including platelet count and glomerular filtration rate is highly predictive of survival in patients with refractory ascites treated with transjugular intrahepatic porto-systemic shunt and could be used to select patients for this procedure.

Keywords: Ascitis; Cirrhosis; Survival; TIPS.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Ascites / etiology
  • Ascites / mortality*
  • Ascites / surgery*
  • Biopsy, Needle
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • France
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Kidney / surgery
  • Liver / surgery
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / mortality*
  • Liver Cirrhosis / surgery*
  • Liver Function Tests
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Portasystemic Shunt, Transjugular Intrahepatic / methods*
  • Proportional Hazards Models
  • Recurrence
  • Retrospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Sex Factors
  • Survival Rate
  • Treatment Outcome